TSX open
Loading markets…

Advertisement

Stocks

Why Avricore Health Inc stock is plummeting today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:AVCR.V

Follow AVCR

Photos provided by Pexels

Avricore Health Inc's stock is feeling the pressure, dropping significantly in today's trading session.

Avricore Health Inc (AVCR.V) is down 15.38% in today's trading. Investors are questioning whether the company's recent gains can hold up amid ongoing market volatility.

Advertisement

Avricore Health Inc

AVCR.V

Full stock page →

AVCR.V

Avricore Health Inc

Source:WealthAwesomeWealthAwesome
↓ $0.03 (-31.25%)
120 day period
$0.05$0.07$0.09Jan 23May 25Sep 29

Market cap

$6.95M

52W high

$0.10

52W low

$0.04

1W change

-8.33%

Beta

0.36

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on AVCR's historical volatility

HistoricalForecast68%95%
C$0.00C$0.12C$0.24C$0.36C$0.48C$0.60TodayMar 31Jun 19Sep 29Nov 11Dec 25Feb 6

30-Day Vol

209.0%

Annualized

90-Day Vol

155.6%

Annualized

Trend (90d)

-36.5%

Annualized drift

90d Mean

C$0.05

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.05C$0.03 – C$0.11
60 trading daysC$0.05C$0.02 – C$0.14
90 trading daysC$0.05C$0.01 – C$0.17

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: The drop in Avricore Health's stock highlights the risks of investing in companies with limited market capitalization and uncertain revenue streams.

Stock Price Drops to CA$0.06

Avricore Health's market cap now stands at CA$6.95 million, reflecting investor skepticism following today's decline.

Bull case

Despite today's setback, Avricore Health's recent partnerships and plans to expand its HealthTab™ platform could set the stage for future growth if they are executed well.

Bear case

The sharp drop in stock price raises concerns about investor confidence and whether the company can maintain its momentum after its recent financing and expansion announcements.

Market Reaction to Recent Developments

Advertisement

Even with recent news, like a collaboration agreement with Abbott for point-of-care testing, Avricore Health's stock hasn't attracted the expected investor interest. Today's market reaction suggests that investors may doubt the company's ability to take advantage of these opportunities.

Financing and Future Prospects

Avricore Health recently closed a CA$1.254 million financing deal, issuing shares at a low price of CA$0.05. While this funding could help support its expansion efforts, today's drop raises questions about whether investors believe the company can effectively use these funds to drive growth.

Investor Sentiment and Market Cap Implications

With a current market cap of CA$6.95 million, the significant drop in stock price indicates a shift in investor sentiment. Ongoing volatility may discourage potential investors, especially in a market where confidence is crucial for small-cap companies like Avricore Health.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 30, 2026
Last Updated: September 30, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement